TUMOR-NECROSIS-FACTOR-ALPHA PROMOTES REPLICATION AND PATHOGENICITY OF RAT CYTOMEGALOVIRUS

被引:46
作者
HAAGMANS, BL
STALS, FS
VANDERMEIDE, PH
BRUGGEMAN, CA
HORZINEK, MC
SCHIJNS, VECJ
机构
[1] UNIV UTRECHT, FAC VET, DEPT INFECT DIS & IMMUNOL, DIV VIROL, 3584 CL UTRECHT, NETHERLANDS
[2] UNIV LIMBURG, DEPT MED MICROBIOL, MAASTRICHT, NETHERLANDS
[3] TNO, ITRI, DEPT INFECT & CHRON DIS, RIJSWIJK, NETHERLANDS
关键词
D O I
10.1128/JVI.68.4.2297-2304.1994
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We investigated the role of tumor necrosis factor alpha (TNF-alpha) in the pathogenesis of rat cytomegalovirus (RCMV) infection. TNF-alpha levels found in the sera of radiation-immunosuppressed rats in the course of infection (>350 pg/ml) correlated with the development of RCMV disease. Administration of anti-TNF-alpha antibodies strongly reduced the severity of pneumonia and led to a reduction in virus titers. In immunocompetent rats, anti-TNF-alpha antibodies also significantly suppressed viral replication. Conversely, administration of TNF-alpha augmented RCMV replication and aggravated the disease signs. In vitro, TNF-alpha enhanced RCMV replication in the macrophage, whereas a reduction of viral replication was observed in fibroblasts, indicating that the effect on viral replication is cell type specific. Besides activation of viral replication and exacerbation of RCMV disease, TNF-alpha also favored lymphoid and hematopoietic tissue reconstitution after irradiation, which may contribute to antiviral resistance and survival. This finding demonstrates the protean nature of TNF-alpha, with both beneficial and adverse effects for the host. Our results suggest that TNF-alpha plays an important role in modulating the pathogenesis of RCMV infection.
引用
收藏
页码:2297 / 2304
页数:8
相关论文
共 41 条
[1]  
ADERKA D, 1986, J IMMUNOL, V136, P2938
[2]  
BEUTLER B, 1987, NEW ENGL J MED, V316, P379
[3]   ISOLATION OF A CYTOMEGALOVIRUS-LIKE AGENT FROM WILD RATS [J].
BRUGGEMAN, CA ;
MEIJER, H ;
DORMANS, PHJ ;
DEBIE, WMH ;
GRAULS, GELM ;
VANBOVEN, CPA .
ARCHIVES OF VIROLOGY, 1982, 73 (3-4) :231-241
[4]   TUMOR-NECROSIS-FACTOR-ALPHA IS INVOLVED IN MOUSE GROWTH AND LYMPHOID-TISSUE DEVELOPMENT [J].
DEKOSSODO, S ;
GRAU, GE ;
DANEVA, T ;
POINTAIRE, P ;
FOSSATI, L ;
ODY, C ;
ZAPF, J ;
PIGUET, PF ;
GAILLARD, RC ;
VASSALLI, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (05) :1259-1264
[5]  
DUDDING L, 1989, J IMMUNOL, V143, P3343
[6]   TUMOR NECROSIS FACTOR A ACTIVATES HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 THROUGH INDUCTION OF NUCLEAR FACTOR BINDING TO THE NF-KAPPA-B SITES IN THE LONG TERMINAL REPEAT [J].
DUH, EJ ;
MAURY, WJ ;
FOLKS, TM ;
FAUCI, AS ;
RABSON, AB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (15) :5974-5978
[7]   A HIGHLY SENSITIVE CELL-LINE, WEHI-164 CLONE 13, FOR MEASURING CYTOTOXIC FACTOR TUMOR-NECROSIS-FACTOR FROM HUMAN-MONOCYTES [J].
ESPEVIK, T ;
NISSENMEYER, J .
JOURNAL OF IMMUNOLOGICAL METHODS, 1986, 95 (01) :99-105
[8]   CYTOMEGALOVIRUS VIREMIA INCREASES WITH PROGRESSIVE IMMUNE-DEFICIENCY IN PATIENTS INFECTED WITH HTLV-III [J].
FIALA, M ;
CONE, LA ;
CHANG, CM ;
MOCARSKI, ES .
AIDS RESEARCH, 1986, 2 (03) :175-181
[9]   TUMOR-NECROSIS-FACTOR (CACHECTIN) AS AN ESSENTIAL MEDIATOR IN MURINE CEREBRAL MALARIA [J].
GRAU, GE ;
FAJARDO, LF ;
PIGUET, PF ;
ALLET, B ;
LAMBERT, PH ;
VASSALLI, P .
SCIENCE, 1987, 237 (4819) :1210-1212
[10]  
GRUNDY JE, 1987, LANCET, V2, P996